PFBT
DNTH icon

Parkside Financial Bank & Trust’s Dianthus Therapeutics DNTH Stock Holding History

Parkside Financial Bank & Trust’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$102K Hold
1,050
– – 0.01% 739
2026
Q1 		$88.1K Buy
1,050
+100
+11% +$5.79K 0.01% 736
2025
Q4 		$39.1K Hold
950
– – ﹤0.01% 1055
2025
Q3 		$37.4K Buy
950
+540
+132% +$13.8K ﹤0.01% 1034
2025
Q2 		$7.64K Buy
410
+25
+6% +$469 ﹤0.01% 1573
2025
Q1 		$6.98K Hold
385
– – ﹤0.01% 1534
2024
Q4 		$8.39K Hold
385
– – ﹤0.01% 1326
2024
Q3 		$10.5K Buy
+385
New +$10.7K ﹤0.01% 1230

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

Parkside Financial Bank & Trust's DNTH Position: Q2 2026 in Review

Parkside Financial Bank & Trust held its Dianthus Therapeutics (DNTH) position steady in Q2 2026 at 1,050 shares worth $102K. The position accounts for 0.01% of the portfolio, ranked #739.

Parkside Financial Bank & Trust first reported a position in DNTH in Q3 2024 and has held it in 8 quarters since. 270 funds tracked by Wall St. Rank hold DNTH as of Q2 2026.

  • Parkside Financial Bank & Trust held 1,050 shares of Dianthus Therapeutics worth $102K as of Q2 2026.
  • Parkside Financial Bank & Trust left its Dianthus Therapeutics share count unchanged in Q2 2026.
  • Dianthus Therapeutics made up 0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #739 holding.
  • Parkside Financial Bank & Trust first reported a position in Dianthus Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • 270 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.